Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Alternative 10 mg/mL Liquid Formulation of ACY 1215 (Ricolinostat) in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02088398
Recruitment Status : Completed
First Posted : March 17, 2014
Last Update Posted : September 11, 2014
Sponsor:
Information provided by (Responsible Party):
Acetylon Pharmaceuticals Incorporated

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2014
Actual Study Completion Date : April 2014